BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38669542)

  • 1. Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    Cetinsoy O; Anyanwu I; Krishnanand H; Natarajan G; Ramachandran N; Thomas A; Brookes KJ
    J Alzheimers Dis; 2024; 99(1):241-250. PubMed ID: 38669542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.
    Ertekin-Taner N; Ronald J; Feuk L; Prince J; Tucker M; Younkin L; Hella M; Jain S; Hackett A; Scanlin L; Kelly J; Kihiko-Ehman M; Neltner M; Hersh L; Kindy M; Markesbery W; Hutton M; de Andrade M; Petersen RC; Graff-Radford N; Estus S; Brookes AJ; Younkin SG
    Hum Mol Genet; 2005 Feb; 14(3):447-60. PubMed ID: 15615772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits.
    Ozturk A; Minster RL; DeKosky ST; Kamboh MI
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):79-82. PubMed ID: 16967469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
    Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation.
    Zhao Y; Yu B; Liu X; Hu J; Yang Y; Namei E; Yang B; Bai Y; Qian Y; Li H
    Reproduction; 2020 Dec; 160(6):853-862. PubMed ID: 33112787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
    Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
    Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
    Cox MB; Bowden NA; Scott RJ; Lechner-Scott J
    Mult Scler; 2014 Apr; 20(4):489-91. PubMed ID: 23897640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.
    Wu W; Jiang H; Wang M; Zhang D
    Am J Alzheimers Dis Other Demen; 2013 Aug; 28(5):517-23. PubMed ID: 23813610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction.
    Xu J; Li W; Bao X; Ding H; Chen J; Zhang W; Sun K; Wang J; Wang X; Wang H; Yu H; Song W; Ma W; Zhang L; Wang C; Wang D; Hui R
    Clin Sci (Lond); 2010 Jul; 119(8):353-9. PubMed ID: 20518747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2.
    Finckh U; van Hadeln K; Müller-Thomsen T; Alberici A; Binetti G; Hock C; Nitsch RM; Stoppe G; Reiss J; Gal A
    Neurogenetics; 2003 Aug; 4(4):213-7. PubMed ID: 12898287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits.
    Papassotiropoulos A; Tsolaki M; Wollmer MA; Molyva D; Thal DR; Huynh KD; Tracy J; Staehelin HB; Monsch AU; Nitsch RM; Hock C
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):21-3. PubMed ID: 15558716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Lee YL
    Clin Chim Acta; 2011 Jan; 412(1-2):194-8. PubMed ID: 20937265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between urokinase-plasminogen activator gene T4065C polymorphism and risk of mitral valve prolapse.
    Chou HT; Chen YT; Wu JY; Tsai FJ
    Int J Cardiol; 2004 Aug; 96(2):165-70. PubMed ID: 15262029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease.
    Bagnoli S; Tedde A; Cellini E; Rotondi M; Nacmias B; Sorbi S
    Neurogenetics; 2005 Feb; 6(1):53-4. PubMed ID: 15616835
    [No Abstract]   [Full Text] [Related]  

  • 15. Significant association of urokinase plasminogen activator Pro141Leu with serum lipid profiles in a Japanese population.
    Tamura T; Morita E; Kawai S; Okada R; Naito M; Wakai K; Hori Y; Kondo T; Hamajima N
    Gene; 2013 Jul; 524(2):363-7. PubMed ID: 23628797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.
    Myers AJ; Marshall H; Holmans P; Compton D; Crook RJ; Mander AP; Nowotny P; Smemo S; Dunstan M; Jehu L; Wang JC; Hamshere M; Morris JC; Norton J; Chakraventy S; Tunstall N; Lovestone S; Petersen R; O'Donovan M; Jones L; Williams J; Owen MJ; Hardy J; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):29-37. PubMed ID: 14681909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline.
    Barton SJ; Koppelman GH; Vonk JM; Browning CA; Nolte IM; Stewart CE; Bainbridge S; Mutch S; Rose-Zerilli MJ; Postma DS; Maniatis N; Henry AP; Hall IP; Holgate ST; Tighe P; Holloway JW; Sayers I
    J Allergy Clin Immunol; 2009 Jun; 123(6):1391-400.e17. PubMed ID: 19443020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor.
    Dowsett J; Ferkingstad E; Rasmussen LJH; Thørner LW; Magnússon MK; Sugden K; Thorleifsson G; Frigge M; Burgdorf KS; Ostrowski SR; Sørensen E; Erikstrup C; Pedersen OB; Hansen TF; Banasik K; Brunak S; ; Tragante V; Lund SH; Stefansdottir L; Gunnarson B; Poulton R; Arseneault L; Caspi A; Moffitt TE; Gudbjartsson D; Eugen-Olsen J; Stefánsson H; Stefánsson K; Ullum H
    Commun Biol; 2021 Jun; 4(1):655. PubMed ID: 34079037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of urokinase-type plasminogen activator with asthma and atopy.
    Bégin P; Tremblay K; Daley D; Lemire M; Claveau S; Salesse C; Kacel S; Montpetit A; Becker A; Chan-Yeung M; Kozyrskyj AL; Hudson TJ; Laprise C
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1109-16. PubMed ID: 17363771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLAUR polymorphisms and lung function in UK smokers.
    Stewart CE; Hall IP; Parker SG; Moffat MF; Wardlaw AJ; Connolly MJ; Ruse C; Sayers I
    BMC Med Genet; 2009 Oct; 10():112. PubMed ID: 19878584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.